Digital health tools for PSP and Lewy body dementia
Part of Brain & nervous system, Eyes & vision, Mental health clinical trials.
This study tests digital health tools (like sensors or apps) to track symptoms of progressive supranuclear palsy (PSP) or dementia with Lewy bodies (DLB) at home. It may help researchers understand how these conditions progress and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 89 years old.
- You have been diagnosed with probable progressive supranuclear palsy (PSP), probable mild cognitive impairment with Lewy bodies (MCI-LB), or probable dementia with Lewy bodies (DLB).
- You can walk at least 10 steps with minimal help, like using a cane.
- You have a caregiver or study partner who can help you with the study.
- You speak and read English fluently.
- You do not have very frequent falls (more than 5 falls per month).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests potential new treatments for progressive supranuclear palsy (PSP), a brain disorder affecting movement, balance, and thinking. It aims to see if these treatments are safe and slow the disease. You may be able to join if you have a specific type of PSP and are in fairly good health.
This study looks at how brain function changes over time in people with Lewy body disease or Alzheimer's. Researchers will use memory tests, MRI scans, and EEG (a painless brain-wave recording) to track these changes, and you will need a family member or friend to help report on your daily life.
This study helps people understand a protein called alpha-synuclein that may be related to memory problems and movement disorders. Researchers will either test your spinal fluid or skin to look for this protein, then discuss the results with you and measure how you're doing over time.
This study looks at a protein called alpha-synuclein in spinal fluid to see if it can help diagnose dementia with Lewy bodies and other related conditions. It may help doctors tell the difference between different types of dementia.
This trial follows people with probable Lewy body dementia over several years to see how the brain changes on MRI and on memory/thinking tests. It may help researchers understand disease progression and improve future care for Lewy body dementia.
This study looks at genetic factors in people with PSP, CBS, MSA, or similar brain conditions, and also in their family members. It involves genetic testing to learn more about these diseases and may help find new treatments.
Hear when a new PSP trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.